Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Audrey Andrews
Authored Items
Treating with Checkpoint Inhibitors—Figure $1 Million per Patient
Audrey Andrews
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
ASCO and NCI Launch Largest Precision Medicine Trials Using Real-World Evidence
Audrey Andrews
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
FDA Approves Mirvaso, First and Only Treatment Available for Erythema in Rosacea
Audrey Andrews
Payer Perspectives in Dermatology
in
Rosacea
Experts Debate Value of Bevacizumab in Newly Diagnosed Glioblastoma
Audrey Andrews
August 2013 Vol 6, No 6 Special Issue
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Audrey Andrews
August 2013 Vol 6, No 6 Special Issue
Nearly 1 in 5 Patients with Cancer Reports Financial Distress
Audrey Andrews
August 2013 Vol 6, No 6 Special Issue
Immunotherapies Take Center Stage in Melanoma
Audrey Andrews
August 2013 Vol 6, No 6 Special Issue
in
Melanoma
Four-Drug Induction and 2-Drug Maintenance Boost Overall Survival in Patients with Newly Diagnosed Myeloma
Audrey Andrews
February 2013 Vol 6, No 1, Special Issue
in
Multiple Myeloma
Evidence Lacking for Eliminating Prophylactic Platelet Transfusions
Audrey Andrews
February 2013 Vol 6, No 1, Special Issue
in
Leukemia
Ibrutinib: It’s Not Just for Leukemia
Audrey Andrews
February 2013 Vol 6, No 1, Special Issue
in
Leukemia
Ara-C Should Be Part of Conditioning Regimen in Young Patients with Mantle-Cell Lymphoma
Audrey Andrews
February 2013 Vol 6, No 1, Special Issue
in
Lymphoma
Novel T-DM1 Prolongs Remission in Metastatic Breast Cancer: A New “Smart Bomb”
Audrey Andrews
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
in
Breast Cancer
Novel Agents Boost Survival in Metastatic Melanoma
Audrey Andrews
August 2011 Vol 4, No 4, Special Issue
in
Melanoma
Last modified: September 6, 2011